APTO(Delisted)
Aptose Biosciences·NASDAQ
--
--(--)
APTO Filings
Filing Date
Form Description
Form Type
2026-03-31
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-31 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-31
Form 8-K - Current report
Key Events
2026-03-31 · Key Events
Form 8-K - Current report
2026-03-31
Form 8-K - Current report
Key Events
2026-03-31 · Key Events
Form 8-K - Current report
2026-03-23
Form RW - Registration Withdrawal Request
2026-03-23 ·
Form RW - Registration Withdrawal Request
2026-03-23
Form 8-K - Current report
Key Events
2026-03-23 · Key Events
Form 8-K - Current report
2026-03-23
Form 8-K - Current report
Key Events
2026-03-23 · Key Events
Form 8-K - Current report
2026-03-19
Form 8-K - Current report
Key Events
2026-03-19 · Key Events
Form 8-K - Current report
2026-02-24
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2026-02-24 ·
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2026-02-24
Form 8-K - Current report
Key Events
2026-02-24 · Key Events
Form 8-K - Current report
2026-02-24
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
2026-02-24 ·
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
